vs

Side-by-side financial comparison of Central Plains Bancshares, Inc. (CPBI) and Cytosorbents Corp (CTSO). Click either name above to swap in a different company.

Cytosorbents Corp is the larger business by last-quarter revenue ($9.2M vs $7.2M, roughly 1.3× Central Plains Bancshares, Inc.). Central Plains Bancshares, Inc. runs the higher net margin — 16.4% vs -59.5%, a 75.9% gap on every dollar of revenue. On growth, Central Plains Bancshares, Inc. posted the faster year-over-year revenue change (14.8% vs 0.9%). Central Plains Bancshares, Inc. produced more free cash flow last quarter ($2.2M vs $-4.9M). Over the past eight quarters, Central Plains Bancshares, Inc.'s revenue compounded faster (11.9% CAGR vs 1.3%).

Huntington Bancshares Incorporated is an American bank holding company headquartered in Columbus, Ohio. Its banking subsidiary, The Huntington National Bank, operates 1,047 banking offices, primarily in the Midwest: 459 in Ohio, 290 in Michigan, 80 in Minnesota, 51 in Pennsylvania, 45 in Indiana, 35 in Illinois, 32 in Colorado, 29 in West Virginia, 16 in Wisconsin, 10 in Kentucky, and one in North Carolina.

CytoSorbents Corporation is a publicly traded company located in Princeton, New Jersey.

CPBI vs CTSO — Head-to-Head

Bigger by revenue
CTSO
CTSO
1.3× larger
CTSO
$9.2M
$7.2M
CPBI
Growing faster (revenue YoY)
CPBI
CPBI
+13.9% gap
CPBI
14.8%
0.9%
CTSO
Higher net margin
CPBI
CPBI
75.9% more per $
CPBI
16.4%
-59.5%
CTSO
More free cash flow
CPBI
CPBI
$7.2M more FCF
CPBI
$2.2M
$-4.9M
CTSO
Faster 2-yr revenue CAGR
CPBI
CPBI
Annualised
CPBI
11.9%
1.3%
CTSO

Income Statement — Q3 FY2026 vs Q4 FY2025

Metric
CPBI
CPBI
CTSO
CTSO
Revenue
$7.2M
$9.2M
Net Profit
$1.2M
$-5.5M
Gross Margin
73.7%
Operating Margin
20.6%
-47.5%
Net Margin
16.4%
-59.5%
Revenue YoY
14.8%
0.9%
Net Profit YoY
23.6%
27.4%
EPS (diluted)
$0.31
$-0.09

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CPBI
CPBI
CTSO
CTSO
Q4 25
$7.2M
$9.2M
Q3 25
$6.8M
$9.5M
Q2 25
$6.6M
$9.6M
Q1 25
$6.4M
$8.7M
Q4 24
$6.2M
$9.2M
Q3 24
$6.1M
$8.6M
Q2 24
$5.9M
$8.8M
Q1 24
$5.7M
$9.0M
Net Profit
CPBI
CPBI
CTSO
CTSO
Q4 25
$1.2M
$-5.5M
Q3 25
$882.0K
$-3.2M
Q2 25
$988.0K
$1.9M
Q1 25
$848.0K
$-1.5M
Q4 24
$951.0K
$-7.6M
Q3 24
$952.0K
$-2.8M
Q2 24
$903.0K
$-4.3M
Q1 24
$903.0K
$-6.1M
Gross Margin
CPBI
CPBI
CTSO
CTSO
Q4 25
73.7%
Q3 25
70.3%
Q2 25
70.9%
Q1 25
71.1%
Q4 24
68.4%
Q3 24
61.0%
Q2 24
73.5%
Q1 24
76.5%
Operating Margin
CPBI
CPBI
CTSO
CTSO
Q4 25
20.6%
-47.5%
Q3 25
16.4%
-30.2%
Q2 25
18.7%
-37.6%
Q1 25
16.7%
-44.5%
Q4 24
19.1%
-37.1%
Q3 24
18.8%
-56.1%
Q2 24
18.8%
-40.4%
Q1 24
18.7%
-51.8%
Net Margin
CPBI
CPBI
CTSO
CTSO
Q4 25
16.4%
-59.5%
Q3 25
13.0%
-33.4%
Q2 25
15.0%
20.2%
Q1 25
13.3%
-16.9%
Q4 24
15.2%
-82.7%
Q3 24
15.5%
-32.1%
Q2 24
15.3%
-48.6%
Q1 24
15.8%
-67.7%
EPS (diluted)
CPBI
CPBI
CTSO
CTSO
Q4 25
$0.31
$-0.09
Q3 25
$0.23
$-0.05
Q2 25
$0.26
$0.03
Q1 25
$0.22
$-0.02
Q4 24
$0.25
$-0.14
Q3 24
$0.25
$-0.05
Q2 24
$0.24
$-0.08
Q1 24
$-0.11

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CPBI
CPBI
CTSO
CTSO
Cash + ST InvestmentsLiquidity on hand
$28.1M
$6.2M
Total DebtLower is stronger
Stockholders' EquityBook value
$87.8M
$5.9M
Total Assets
$535.7M
$44.2M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CPBI
CPBI
CTSO
CTSO
Q4 25
$28.1M
$6.2M
Q3 25
$8.9M
$7.5M
Q2 25
$7.9M
$10.2M
Q1 25
$28.7M
$11.6M
Q4 24
$6.6M
$3.3M
Q3 24
$9.9M
$5.7M
Q2 24
$5.5M
$8.5M
Q1 24
$11.5M
$8.6M
Total Debt
CPBI
CPBI
CTSO
CTSO
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
$13.8M
Q2 24
$13.7M
Q1 24
$4.4M
Stockholders' Equity
CPBI
CPBI
CTSO
CTSO
Q4 25
$87.8M
$5.9M
Q3 25
$86.2M
$9.0M
Q2 25
$84.6M
$11.6M
Q1 25
$83.3M
$14.5M
Q4 24
$81.3M
$11.1M
Q3 24
$81.6M
$13.4M
Q2 24
$79.2M
$17.4M
Q1 24
$78.3M
$19.6M
Total Assets
CPBI
CPBI
CTSO
CTSO
Q4 25
$535.7M
$44.2M
Q3 25
$510.0M
$45.8M
Q2 25
$500.9M
$48.0M
Q1 25
$508.7M
$50.8M
Q4 24
$484.3M
$47.4M
Q3 24
$482.0M
$47.8M
Q2 24
$466.6M
$53.4M
Q1 24
$463.3M
$47.1M
Debt / Equity
CPBI
CPBI
CTSO
CTSO
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
1.03×
Q2 24
0.78×
Q1 24
0.23×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CPBI
CPBI
CTSO
CTSO
Operating Cash FlowLast quarter
$2.3M
$-4.8M
Free Cash FlowOCF − Capex
$2.2M
$-4.9M
FCF MarginFCF / Revenue
31.1%
-53.4%
Capex IntensityCapex / Revenue
0.8%
1.2%
Cash ConversionOCF / Net Profit
1.95×
TTM Free Cash FlowTrailing 4 quarters
$-718.0K
$-12.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CPBI
CPBI
CTSO
CTSO
Q4 25
$2.3M
$-4.8M
Q3 25
$1.1M
$-2.6M
Q2 25
$-96.0K
$-1.5M
Q1 25
$4.5M
$-3.5M
Q4 24
$674.0K
$-2.3M
Q3 24
$1.2M
$-2.5M
Q2 24
$505.0K
$-4.8M
Q1 24
$5.7M
$-4.8M
Free Cash Flow
CPBI
CPBI
CTSO
CTSO
Q4 25
$2.2M
$-4.9M
Q3 25
$888.0K
$-2.6M
Q2 25
$-766.0K
$-1.5M
Q1 25
$-3.1M
$-3.5M
Q4 24
$-1.5M
$-2.4M
Q3 24
$-975.0K
$-2.6M
Q2 24
$35.0K
$-4.8M
Q1 24
$3.4M
$-4.9M
FCF Margin
CPBI
CPBI
CTSO
CTSO
Q4 25
31.1%
-53.4%
Q3 25
13.1%
-27.3%
Q2 25
-11.6%
-16.1%
Q1 25
-48.0%
-39.7%
Q4 24
-23.7%
-26.3%
Q3 24
-15.9%
-30.4%
Q2 24
0.6%
-54.4%
Q1 24
59.9%
-54.2%
Capex Intensity
CPBI
CPBI
CTSO
CTSO
Q4 25
0.8%
1.2%
Q3 25
3.6%
0.2%
Q2 25
10.2%
0.4%
Q1 25
117.7%
0.0%
Q4 24
34.5%
0.8%
Q3 24
35.4%
1.8%
Q2 24
8.0%
0.2%
Q1 24
39.9%
0.5%
Cash Conversion
CPBI
CPBI
CTSO
CTSO
Q4 25
1.95×
Q3 25
1.28×
Q2 25
-0.10×
-0.78×
Q1 25
5.26×
Q4 24
0.71×
Q3 24
1.26×
Q2 24
0.56×
Q1 24
6.32×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CPBI
CPBI

Segment breakdown not available.

CTSO
CTSO

Direct$5.1M55%
Distributors And Strategic Partners$4.2M45%

Related Comparisons